Lg Innotek Co., Ltd.

Lg Chem, Ltd

Lg Life Sciences, Limited

Other

Korea Advanced Institute of Science and Technology

Eun Sil Choi

Young Kwan Kim

Hyun Woo Joo

Sang Yun Park

Sang Dae Lee

Vasily Artemov

Sung Wook Kim

Byung Gyu Kim

Tae Hun Kim

Dong Wook Kim

Hyun Seo Park

Chang Seok Lee

Ki Young Song

Hyun Jung Park

Myung Hoon Jung

Heui Sul Park

Sung Pil Choi

Seung Yup Paek

Seung Wan Kang

Tae Jae Lee

Jeong Tak Oh

Sung J Uhm

Deok Seong Park

Wan Su Park

Geun Tae Kim

Ki Chul Koo

Myoung Yeol Kim

Ok Ku Park

Cheol Kyu Jung

Jeong Uk Song

Dong W Yu

Ji Ho Hong

Hee Dong Park

Hye Won Ahn

Su Jin Yeo

Compounds having the chemical formula 1, a method for producing the compounds of chemical formula 1, a pharmaceutical composition comprising same, and use thereof as a GPR120 agonist for prevention or treatment of inflammation or metabolic diseases such as diabetes, complications from diabetes, obesity, non-alcoholic fatty liver disease, fatty liver disease, and osteoporosis.

Biaryl derivative as GPR120 agonist

The present invention relates to biaryl derivatives of Formula 1, a method for preparing the same, a pharmaceutical composition comprising the same and use thereof. The biaryl derivatives of Formula 1 according to the present invention promote GLP-1 formation in the gastrointestinal tract and improve insulin resistance in the liver or in muscle due to anti-inflammatory action in macrophages, lipocytes, etc., and can accordingly be effectively used for preventing or treating diabetes, complications of diabetes, obesity, non-alcoholic fatty liver, steatohepatitis, osteoporosis or inflammation.

Biaryl derivatives as GPR120 agonists

The present invention relates to thioaryl derivatives of Formula 1 as defined in the specification, a method for preparing the same, a pharmaceutical composition comprising the same and use thereof. The thioaryl derivatives of Formula 1 according to the present invention promote GLP-1 formation in the gastrointestinal tract and improve insulin resistance in macrophages, pancreas cells, etc. due to anti-inflammatory action, and can accordingly be effectively used for preventing or treating diabetes, complications of diabetes, inflammation, obesity, non-alcoholic fatty liver, steatohepatitis or osteoporosis.

Thioaryl derivatives as GPR120 agonists

A light emitting device includes a first electrode layer, a second conductive semiconductor layer on the first electrode layer, an active layer on the second conductive semiconductor layer, and a first conductive semiconductor layer on the active layer. An AlGaN layer (where, 0y&#x2266;1) is provided over the first conductive semiconductor layer, and an InGaN pattern (where, 0x&#x2266;1) is provided over the AlGaN layer. A gallium nitride semiconductor layer is provided over the InGaN pattern; and a pad electrode is provided on the gallium nitride semiconductor layer.

Light emitting device and lighting system

Disclosed are a light emitting device, a method of fabricating a light emitting device, a light emitting device package, and a lighting system. The light emitting device includes a first conductive semiconductor layer (), an InGaN layer (where, 0&#x3c;x&#x2266;1) () on the first conductive semiconductor layer (), a GaN layer () on the InGaN layer (), a first AlGaN layer (where, 0&#x3c;y1&#x2266;1) () on the GaN layer (), an active layer () on the first AlGaN layer (), and a second conductive semiconductor layer () on the active layer ().

A light emitting device includes a first semiconductor layer having a first conductive dopant, an active layer on the first semiconductor layer, an electron blocking layer on the active layer, a carrier injection layer between the active layer and the electron blocking layer, and a second semiconductor layer having a second conductive dopant on the electron blocking layer. The carrier injection layer includes the first conductive dopant and the second conductive dopant, and the first conductive dopant of the carrier injection layer has a concentration lower than a concentration of the second conductive dopant.

Light emitting device

The present invention relates to novel compounds which are effective as an inhibitor for xanthine oxidase, a process for preparing the same, and a pharmaceutical composition comprising a therapeutically effective amount of the same.

Compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same

A process for preparing phthalic acid esters of formula (I) which comprises reacting the phthalic acids of formula (II) with an aliphatic alcohol in the presence of a catalyst consisting essentially of the dialkyltinoxides of formula (III): ##STR1## wherein R and R.sub.1 are the same or different and include both straight and branch chain aliphatic alkyl groups containing 4 to 13 carbon atoms and R.sub.2 and R.sub.3 are straight or branch chain aliphatic alkyl groups containing 1 to 8 carbon atoms.

Process for producing phthalic acid esters

An automated mechanism for imparting life-like movement to limbs of a mechanical toy. The mechanism has at least a pair of limbs which are moved by a connecting rod and cam. Each limb has a first member pivotally mounted at its one end to a gearbox and the other end to an opposing end of a second member to form joints therebetween and axes of rotation. The connecting rod has its one end pivotally connected to the cam and the other end to the second limb member at a distance from the joint formed between the two members. The cam is connected to a motor through a gear mechanism. Two fulcrum pins are mounted at the end of each first limb member adjacent the gearbox to form a space therebetween with the connecting rod being positioned for movement within that space. The pins act as fulcrums for the rod to transfer a predetermined movement to the second limb member when the rod engages the pins. The rotation of the cam means and the movement of the connecting rod give an oscillation motion for the first and second members about their respective axes of rotation and translational motion of the axis of rotation of the second member to simulate a life-like movement to the limbs.

Automated mechanism for imparting movement to limbs of a mechanical toy

Growing community of inventors

Seoul, South Korea

Eun Sil Choi